title: Synthetic nucleic acid delivery systems: present and perspectives.
abstract: Self-assembled synthetic gene delivery systems represent the bottom-up approach to gene delivery and gene silencing, in which scientists are designing novel cationic and procationic amphiphiles that can pack, transport, and deliver nucleic acids to various targets in the body in a controlled manner. These supramolecular assemblies are safer than viruses, but they are lagging behind them in efficiency. We are presenting recent progress that has narrowed this gap through better understanding the delivery barriers and incorporation of this knowledge in the design of novel synthetic amphiphiles, formulations, and revolutionary screening and optimization processes. Structure-properties and structure-activity relationships were drawn within each amphiphile class, presenting the cellular and animal models used to generate them. We are also revealing pertinent in vitro/in vivo correlations that emphasize promising amphiphiles and successful formulation optimization efforts for efficient in vivo nucleic acid delivery, together with main organ targets and diseases treatable with these revolutionary technologies.
authors: †Department of Pharmaceutical Sciences and Moulder Center for Drug Discovery Research, Temple University School of Pharmacy, 3307 North Broad Street, Philadelphia, Pennsylvania 19140, United States.
authors: Bogdan
authors: B
authors: Draghici
authors: †Department of Pharmaceutical Sciences and Moulder Center for Drug Discovery Research, Temple University School of Pharmacy, 3307 North Broad Street, Philadelphia, Pennsylvania 19140, United States.|‡Temple Materials Institute, 1803 North Broad Street, Philadelphia, Pennsylvania 19122, United States.
authors: Marc A
authors: MA
authors: Ilies
mesh_terms: D000818:Animals; D002412:Cations / Q000737:chemistry; D002784:Cholesterol / Q000737:chemistry; D002986:Clinical Trials as Topic; D050091:Dendrimers / Q000737:chemistry; D004337:Drug Carriers / Q000737:chemistry; D018014:Gene Transfer Techniques; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008055:Lipids / Q000737:chemistry; D055666:Lipopeptides / Q000737:chemistry; D009696:Nucleic Acids / Q000008:administration & dosage* / Q000737:chemistry*; D010714:Phosphatidylethanolamines / Q000737:chemistry; D034741:RNA, Small Interfering / Q000008:administration & dosage; D013329:Structure-Activity Relationship; D013501:Surface-Active Agents / Q000737:chemistry*
chemical_list: D002412:Cations; D050091:Dendrimers; D004337:Drug Carriers; D008055:Lipids; D055666:Lipopeptides; D009696:Nucleic Acids; D010714:Phosphatidylethanolamines; D034741:RNA, Small Interfering; D013501:Surface-Active Agents; C094877:dioleoyl phosphatidylethanolamine; D002784:Cholesterol